Adagio Medical Holdings, Inc. (ADGM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
26051 Merit Circle
Laguna Hills, CA 92653
United States of America (the)
Phone
949-348-1188
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
41
First IPO Date
August 01, 2024
| Name | Title | Pay | Year Born |
| Todd Usen | Chief Executive Officer & Director | 868,608 | 1967 |
| Deborah Kaster | Chief Financial Officer & Chief Business Officer | 436,882 | 1971 |
| Antwan Gipson | Senior Vice President of Manufacturing & Operations | 0 | N/A |
| Maryline Cullen | VP & Corporate Controller | 0 | N/A |
| Alex Babkin | Chief Technical Officer | 0 | N/A |
| Ilya Grigorov | Vice President of Global Marketing & Product Management | 0 | N/A |
| Marie-Claude Jacques | Senior Vice President of Global Sales | 0 | 1985 |
| Nabil Jubran | Chief Compliance Officer | 0 | N/A |
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.